AIM
WST icon

Achmea Investment Management’s West Pharmaceutical WST Stock Holding History

Achmea Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,822
Closed -$1M – 313
2025
Q3 		$1M Hold
3,822
– – 0.01% 286
2025
Q2 		$836K Hold
3,822
– – 0.01% 315
2025
Q1 		$856K Buy
3,822
+1,113
+41% +$307K 0.01% 338
2024
Q4 		$887K Sell
2,709
-1,945
-42% -$612K 0.01% 364
2024
Q3 		$1.4M Sell
4,654
-2,602
-36% -$797K 0.02% 339
2024
Q2 		$2.39M Sell
7,256
-3,804
-34% -$1.34M 0.04% 299
2024
Q1 		$4.38M Hold
11,060
– – 0.08% 236
2023
Q4 		$3.9M Sell
11,060
-326
-3% -$115K 0.08% 245
2023
Q3 		$4.27M Buy
11,386
+3,824
+51% +$1.48M 0.09% 227
2023
Q2 		$2.89M Buy
7,562
+4,300
+132% +$1.54M 0.06% 300
2023
Q1 		$1.13M Hold
3,262
– – 0.03% 379
2022
Q4 		$719K Sell
3,262
-2,698
-45% -$639K 0.02% 442
2022
Q3 		$1.47M Sell
5,960
-4,433
-43% -$1.35M 0.05% 328
2022
Q2 		$3.14M Sell
10,393
-7,036
-40% -$2.29M 0.1% 222
2022
Q1 		$7.16M Buy
+17,429
New +$6.82M 0.19% 127
2021
Q4 		– Sell
-30,231
Closed -$12.8M – 639
2021
Q3 		$12.8M Sell
30,231
-193
-0.6% -$81.4K 0.39% 51
2021
Q2 		$10.9M Buy
30,424
+879
+3% +$290K 0.37% 56
2021
Q1 		$8.32M Sell
29,545
-1,610
-5% -$461K 0.29% 93
2020
Q4 		$8.83M Buy
31,155
+2,706
+10% +$759K 0.32% 79
2020
Q3 		$7.82M Buy
+28,449
New +$7.53M 0.33% 79

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Achmea Investment Management's WST Position: Q4 2025 in Review

Achmea Investment Management sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 3,822 shares — an estimated $1M sold.

Achmea Investment Management first reported a position in WST in Q3 2020 and held it in 20 quarters. The position peaked at $12.8M in Q3 2021. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Achmea Investment Management reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Achmea Investment Management sold 3,822 West Pharmaceutical shares in Q4 2025, an estimated $1M.
  • Achmea Investment Management first reported a position in West Pharmaceutical in Q3 2020 and held it in 20 quarters.
  • Achmea Investment Management's West Pharmaceutical position peaked at $12.8M in Q3 2021.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.